Article
Influence of CYP2C19*18 and CYP2C19*19 alleles on omeprazole 5-hydroxylation: in vitro functional analysis of recombinant enzymes expressed in Saccharomyces cerevisiae.
Basic & clinical pharmacology & toxicology - 1 Apr 2008
Hanioka Nobumitsu, Tsuneto Yumi, Saito Yoshiro, Maekawa Keiko, Sawada Jun-Ichi, Narimatsu Shizuo
Abstract excerpt
Omeprazole is one of the most widely used proton pump inhibitors for the treatment of gastric acid-related disorders. The major metabolic pathway of omeprazole is 5-hydroxylation, which is catalysed by CYP2C19. In this study, the effect of CYP2C19*18 and CYP2C19*19 alleles on omeprazole 5-hydroxy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
